19

Nachlass von Max Scheler (1874-1928) – BSB Ana 315 (nach 1928)




19

Nachlass von Max Scheler (1874-1928) – BSB Ana 315 (nach 1928)




19

Nachlass von Max Scheler (1874-1928) – BSB Ana 315 (nach 1928)




19

Nachlass von Max Scheler (1874-1928) – BSB Ana 315 (nach 1928)




19

Nachlass von Max Scheler (1874-1928) – BSB Ana 315 (nach 1928)




19

Nachlass von Max Scheler (1874-1928) – BSB Ana 315 (nach 1928)




19

Nachlass von Max Scheler (1874-1928) – BSB Ana 315 (nach 1928)




19

Nachlass von Max Scheler (1874-1928) – BSB Ana 315 (nach 1928)




19

Nachlass von Max Scheler (1874-1928) – BSB Ana 315 (nach 1928)




19

Nachlass von Max Scheler (1874-1928) – BSB Ana 315 (nach 1928)




19

Nachlass von Max Scheler (1874-1928) – BSB Ana 315 (nach 1928)




19

Nachlass von Max Scheler (1874-1928) – BSB Ana 315 (nach 1928)




19

Alter Realkatalog (1501-1952), Teil Bayern - BSB Cbm Cat. 805(1 b (1870)




19

Ein Abend auf den Bergen Op. 25 ([1920?])




19

Alter Realkatalog (1501-1952), Teil Bayern - BSB Cbm Cat. 805(1 b (1870)




19

Alter Realkatalog (1501-1952), Teil Bayern - BSB Cbm Cat. 805(1 b (1870)




19

Alter Realkatalog (1501-1952), Teil Bayern - BSB Cbm Cat. 805(1 b (1870)




19

Alter Realkatalog (1501-1952), Teil Bayern - BSB Cbm Cat. 805(1 b (1870)




19

Alter Realkatalog (1501-1952), Teil Bayern - BSB Cbm Cat. 805(1 b (1870)




19

Alter Realkatalog (1501-1952), Teil Bayern - BSB Cbm Cat. 805(1 b (1870)




19

Alter Realkatalog (1501-1952), Teil Bayern - BSB Cbm Cat. 805(1 b (1870)




19

Alter Realkatalog (1501-1952), Teil Bayern - BSB Cbm Cat. 805(1 b (1870)




19

Alter Realkatalog (1501-1952), Teil Bayern - BSB Cbm Cat. 805(1 b (1870)




19

An opportunity in Covid-19 crisis: Revisit all loan repayment contracts

It is a chance for stakeholders in the banking sector to revisit contractual obligations, say experts




19

To fight a pandemic like Covid-19, India needs overarching healthcare laws

Experts point out in India it is left to individuals to quarantine themselves voluntarily




19

Connecting histories : decolonization and the Cold War in Southeast Asia, 1945-1962 / edited by Christopher E. Goscha and Christian Ostermann




19

Polarizing Javanese society : Islamic, and other visions, c. 1830-1930 / M.C. Ricklefs

Ricklefs, M. C. (Merle Calvin), 1943-




19

Report of the Parliamentary Delegation to the twenty-fifth Annual Meeting of the Asia Pacific Parliamentary Forum, Natadola, Fiji : Natadola, Fiji - 15-19 January 2017

Australia. Parliament. Delegation to the Annual Meeting of the Asia Pacific Parliamentary Forum (25th : 2017 : Natadola, Fiji)




19

Enterprising China : business, economic, and legal developments since 1979 / Linda Yueh

Yueh, Linda Y. (Linda Yi-Chuang)




19

Animism in Southeast Asia / edited by Kaj Århem and Guido Sprenger, with an end comment by Tim Ingold




19

Transcultural justice at the Tokyo Tribunal : the Allied struggle for justice, 1946-48 / edited by Kerstin von Lingen




19

The Indonesian military response to reform in democratic transition : a comparative analysis of three civilian regimes, 1998-2004 / Poltak Partogi Nainggolan

Nainggolan, Poltak Partogi, 1963- author




19

Report of the Parliamentary delegation to the twenty-seventh Annual Meeting of the Asia Pacific Parliamentary Forum, Siem Reap, Cambodia 13-18 January 2019

Australia. Parliament. Delegation to the Annual Meeting of the Asia Pacific Parliamentary Forum (27th : 2019 : Siem Reap, Cambodia)




19

Vichy in the tropics : Pétain's national revolution in Madagascar, Guadeloupe, and Indochina, 1940-1944 / Eric T. Jennings

Jennings, Eric, author




19

How COVID-19 is changing my graduate school experience




19

How we know disinfectants should kill the COVID-19 coronavirus

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking




19

COVID-19 coronavirus weighs on economy, chemicals

Chemical makers and oil producers are pulling back on production, reconsidering investments




19

Sanofi, Regeneron test arthritis drug against COVID-19

New study explores whether dampening IL-6 could address serious coronavirus infections




19

Shortage of RNA extraction kits hampers efforts to ramp up COVID-19 coronavirus testing

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations




19

No evidence to support link between ibuprofen and COVID-19, experts say

WHO does not recommend against taking the drug for fever caused by novel coronavirus infection




19

Ginkgo opens facilities to help COVID-19 coronavirus response

Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines




19

COVID-19 coronavirus quarantines cause rapid drop in air pollution

NO<sub>2</sub> levels have fallen sharply in northern Italy and China




19

How we know disinfectants should kill the COVID-19 coronavirus

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2-specific data are lacking




19

Protein mapping finds 69 potential treatments for COVID-19

Many are FDA-approved drugs that could be repurposed




19

Tension but also harmony over COVID-19 in Europe's chemical industry

Italian workers threaten to strike, but German, UK companies and workers pull together




19

Chloroquine's use to treat COVID-19 is backed by US government, but many questions remain

Old anti-malarial drugs have shown mixed results in the small clinical trials conducted so far




19

Emory-discovered antiviral is poised for COVID-19 clinical trials

The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans




19

Shortage of RNA extraction kits hampers efforts to ramp up COVID-19 testing

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations




19

What can initial remdesivir data tell us about tackling COVID-19?

Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts




19

COVID-19 mostly behind it, China's chemical industry struggles to rev up

Lingering logistic problems and a sputtering economy mean hard times for companies